Novartis Pharmaceuticals announced the establishment of a joint investment company with Qualcomm Ventures to target early stage companies who offer technologies, products or services that "go beyond the pill" to benefit physicians and patients.
Novartis establishing a joint investment company with Qualcomm Ventures of up to USD 100 million to support early stage companies with technologies, products or services that "go beyond the pill".
|Searching for more deal information? Current Partnering offers the following options:
Digital technologies can optimize the value of innovative medicines by providing integrated solutions for physicians and patients and changing the practice of medicine.
Qualcomm Ventures, the venture investment group of Qualcomm Incorporated, is a leading global investor in wireless technologies and one of the most active strategic investors in digital health.
For further deal information visit Current Agreements (subscription required)
Scorecard: Top partnering deals by value in 2014
View: Top biotech companies
Report: Top 50 Big Biotech Partnering and M&A Deal Trends